New Zealand - English - Medsafe (Medicines Safety Authority)

sandoz new zealand limited - tadalafil 20mg - film coated tablet - 20 mg - active: tadalafil 20mg excipient: croscarmellose sodium hypromellose lactose monohydrate magnesium stearate microcrystalline cellulose opadry yellow 32k520009 sorbitan stearate - tadalafil sandoz is indicated for the treatment of: · erectile dysfunction (ed) in adult men. in order for tadalafil sandoz to be effective in treating ed, sexual stimulation is required. · moderate to severe lower urinary tract symptoms (luts) associated with benign prostatic hyperplasia (bph) in adult men · adult men with co-existing ed and luts associated with bph.

New Zealand - English - Medsafe (Medicines Safety Authority)

sandoz new zealand limited - tadalafil 5mg - film coated tablet - 5 mg - active: tadalafil 5mg excipient: croscarmellose sodium hypromellose lactose monohydrate magnesium stearate microcrystalline cellulose opadry yellow 32k520007 sorbitan stearate - tadalafil sandoz is indicated for the treatment of: · erectile dysfunction (ed) in adult men. in order for tadalafil sandoz to be effective in treating ed, sexual stimulation is required. · moderate to severe lower urinary tract symptoms (luts) associated with benign prostatic hyperplasia (bph) in adult men · adult men with co-existing ed and luts associated with bph.

Canada - English - Health Canada

laboratoire riva inc. - tadalafil - tablet - 2.5mg - tadalafil 2.5mg - phosphodiesterase type 5 inhibitors

Canada - English - Health Canada

laboratoire riva inc. - tadalafil - tablet - 5mg - tadalafil 5mg - phosphodiesterase type 5 inhibitors

Canada - English - Health Canada

laboratoire riva inc. - tadalafil - tablet - 10mg - tadalafil 10mg - phosphodiesterase type 5 inhibitors

Canada - English - Health Canada

laboratoire riva inc. - tadalafil - tablet - 20mg - tadalafil 20mg - phosphodiesterase type 5 inhibitors

Australia - English - Department of Health (Therapeutic Goods Administration)

accord healthcare pty ltd - tadalafil, quantity: 20 mg - tablet, film coated - excipient ingredients: lactose monohydrate; microcrystalline cellulose; croscarmellose sodium; hypromellose; sorbitan stearate; magnesium stearate; titanium dioxide; purified talc; triacetin; iron oxide yellow - apo-tadalafil is indicated for the treatment of erectile dysfunction (ed) in adult males

Australia - English - Department of Health (Therapeutic Goods Administration)

accord healthcare pty ltd - tadalafil, quantity: 10 mg - tablet, film coated - excipient ingredients: lactose monohydrate; microcrystalline cellulose; croscarmellose sodium; hypromellose; sorbitan stearate; magnesium stearate; titanium dioxide; purified talc; triacetin; iron oxide yellow - apo-tadalafil is indicated for the treatment of erectile dysfunction (ed) in adult males

Australia - English - Department of Health (Therapeutic Goods Administration)

accord healthcare pty ltd - tadalafil, quantity: 5 mg - tablet, film coated - excipient ingredients: lactose monohydrate; microcrystalline cellulose; croscarmellose sodium; hypromellose; sorbitan stearate; magnesium stearate; titanium dioxide; purified talc; triacetin; iron oxide yellow - apo-tadalafil is indicated for the treatment of: ? erectile dysfunction (ed) in adult males ? moderate to severe lower urinary tract symptoms (luts) associated with benign prostatic hyperplasia (bph) in adult males

Canada - English - Health Canada

accord healthcare inc - tadalafil - tablet - 2.5mg - tadalafil 2.5mg - phosphodiesterase type 5 inhibitors